163 related articles for article (PubMed ID: 36625073)
1. Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swab.
Weimer J; Hüttmann M; Nusilati A; Andreas S; Röseler J; Tribian N; Rogmans C; Stope MB; Dahl E; Mustea A; Stickeler E; Hedemann N; Flörkemeier I; Tiemann K; Magadeeva S; Dempfle A; Arnold N; Maass N; Bauerschlag D
J Cell Mol Med; 2023 Feb; 27(3):379-391. PubMed ID: 36625073
[TBL] [Abstract][Full Text] [Related]
2. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
3. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets.
Herzog C; Marín F; Jones A; Evans I; Reisel D; Redl E; Schreiberhuber L; Paytubi S; Pelegrina B; Carmona Á; Peremiquel-Trillas P; Frias-Gomez J; Pineda M; Brunet J; Ponce J; Matias-Guiu X; de Sanjosé S; Alemany L; Olaitan A; Wong M; Jurkovic D; Crosbie EJ; Rosenthal AN; Bjørge L; Zikan M; Dostalek L; Cibula D; Sundström K; Dillner J; Costas L; Widschwendter M
J Clin Oncol; 2022 Nov; 40(33):3828-3838. PubMed ID: 36001862
[TBL] [Abstract][Full Text] [Related]
4. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
5. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
6. Controversies on Transvaginal Ultrasound Screening for Endometrial Cancer in Asymptomatic Postmenopausal Women.
Tsikouras P; Bacha M; Zervoudis S; Koukouli Z; Iatrakis G; Galazios G; Maroulis G; Virtej I; Onofriescu M
Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):855-60. PubMed ID: 30141611
[TBL] [Abstract][Full Text] [Related]
7. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
8. Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors.
Samuelson E; Nordlander C; Levan G; Behboudi A
Adv Exp Med Biol; 2008; 617():511-7. PubMed ID: 18497076
[TBL] [Abstract][Full Text] [Related]
9. Association of endometrial thickness assessed at trans-vaginal ultrasonography to endometrial cancer in postmenopausal women asymptomatic or with abnormal uterine bleeding.
Ciatto S; Cecchini S; Gervasi G; Landini A; Zappa M; Crocetti E
Radiol Med; 2002; 104(5-6):437-42. PubMed ID: 12589265
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Matsuura M; Yamaguchi K; Tamate M; Satohisa S; Teramoto M; Iwasaki M; Sugita S; Hasegawa T; Koubo R; Takane K; Ikenoue T; Furukawa Y; Saito T
Cancer Sci; 2018 Dec; 109(12):4025-4032. PubMed ID: 30289582
[TBL] [Abstract][Full Text] [Related]
11. Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women.
Zhang L; Guo Y; Qian G; Su T; Xu H
BMC Womens Health; 2022 Dec; 22(1):517. PubMed ID: 36510213
[TBL] [Abstract][Full Text] [Related]
12. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS).
Manchanda R; Saridogan E; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Side L; Gessler S; Jacobs I; Menon U
Arch Gynecol Obstet; 2012 Dec; 286(6):1555-62. PubMed ID: 22865035
[TBL] [Abstract][Full Text] [Related]
13. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
Reijnen C; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; van der Wurff AAM; Ligtenberg MJL; Massuger LFAG; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 May; 146(9):2628-2635. PubMed ID: 31523803
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers.
Susumu N; Aoki D; Noda T; Nagashima Y; Hirao T; Tamada Y; Banno K; Suzuki A; Suzuki N; Tsuda H; Inazawa J; Nozawa S
Int J Gynecol Cancer; 2005; 15(1):70-80. PubMed ID: 15670300
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.
Stewart CJ; Leung YC; Murch A; Peverall J
Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973
[TBL] [Abstract][Full Text] [Related]
18. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Sangtani A; Wang C; Weaver A; Hoppman NL; Kerr SE; Abyzov A; Shridhar V; Staub J; Kocher JA; Voss JS; Podratz KC; Wentzensen N; Kisiel JB; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2020 Feb; 156(2):387-392. PubMed ID: 31787246
[TBL] [Abstract][Full Text] [Related]
19. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
